Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

What causes the insulin resistance underlying obesity?

Hardy OT, Czech MP, Corvera S.

Curr Opin Endocrinol Diabetes Obes. 2012 Apr;19(2):81-7. doi: 10.1097/MED.0b013e3283514e13. Review.

2.

Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.

Lafontan M, Girard J.

Diabetes Metab. 2008 Sep;34(4 Pt 1):317-27. doi: 10.1016/j.diabet.2008.04.001. Epub 2008 Jun 11. Review.

PMID:
18550411
3.

The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ.

Int J Obes (Lond). 2006 Jun;30(6):877-83.

PMID:
16418758
4.

Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals.

Koska J, Stefan N, Permana PA, Weyer C, Sonoda M, Bogardus C, Smith SR, Joanisse DR, Funahashi T, Krakoff J, Bunt JC.

Am J Clin Nutr. 2008 Feb;87(2):295-302.

5.

Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability.

Nov O, Shapiro H, Ovadia H, Tarnovscki T, Dvir I, Shemesh E, Kovsan J, Shelef I, Carmi Y, Voronov E, Apte RN, Lewis E, Haim Y, Konrad D, Bashan N, Rudich A.

PLoS One. 2013;8(1):e53626. doi: 10.1371/journal.pone.0053626. Epub 2013 Jan 16.

6.

Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.

Goran MI, Alderete TL.

Nestle Nutr Inst Workshop Ser. 2012;73:49-60; discussion p61-6. doi: 10.1159/000341287. Epub 2012 Oct 29. Review.

7.

[Role of fatty liver in metabolic syndrome].

Fodor M.

Orv Hetil. 2010 Aug 29;151(35):1430-3. doi: 10.1556/OH.2010.28897. Hungarian.

PMID:
20719718
8.

Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity.

Gealekman O, Guseva N, Hartigan C, Apotheker S, Gorgoglione M, Gurav K, Tran KV, Straubhaar J, Nicoloro S, Czech MP, Thompson M, Perugini RA, Corvera S.

Circulation. 2011 Jan 18;123(2):186-94. doi: 10.1161/CIRCULATIONAHA.110.970145. Epub 2011 Jan 3.

9.

Visceral fat and insulin resistance--causative or correlative?

Frayn KN.

Br J Nutr. 2000 Mar;83 Suppl 1:S71-7. Review.

PMID:
10889795
10.

Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.

Wang XA, Zhang R, Zhang S, Deng S, Jiang D, Zhong J, Yang L, Wang T, Hong S, Guo S, She ZG, Zhang XD, Li H.

Am J Physiol Endocrinol Metab. 2013 Aug 15;305(4):E485-95. doi: 10.1152/ajpendo.00505.2012. Epub 2013 May 21.

11.

Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.

Bozzetto L, Prinster A, Mancini M, Giacco R, De Natale C, Salvatore M, Riccardi G, Rivellese AA, Annuzzi G.

Eur J Clin Invest. 2011 Jan;41(1):39-44. doi: 10.1111/j.1365-2362.2010.02372.x. Epub 2010 Sep 6.

PMID:
20825466
12.

Visceral fat accumulation during lipid overfeeding is related to subcutaneous adipose tissue characteristics in healthy men.

Alligier M, Gabert L, Meugnier E, Lambert-Porcheron S, Chanseaume E, Pilleul F, Debard C, Sauvinet V, Morio B, Vidal-Puig A, Vidal H, Laville M.

J Clin Endocrinol Metab. 2013 Feb;98(2):802-10. doi: 10.1210/jc.2012-3289. Epub 2013 Jan 2.

PMID:
23284008
13.

Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.

Heilbronn L, Smith SR, Ravussin E.

Int J Obes Relat Metab Disord. 2004 Dec;28 Suppl 4:S12-21. Review.

PMID:
15592481
14.

Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes.

Song YS, Lee SK, Jang YJ, Park HS, Kim JH, Lee YJ, Heo YS.

Diabetes Res Clin Pract. 2013 Sep;101(3):341-8. doi: 10.1016/j.diabres.2013.07.002. Epub 2013 Jul 19.

PMID:
23876548
15.

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.

Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P.

Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49. doi: 10.1161/ATVBAHA.107.159228. Epub 2008 Mar 20. Review. Erratum in: Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):e151.

17.

The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation.

Wensveen FM, Valentić S, Šestan M, Turk Wensveen T, Polić B.

Eur J Immunol. 2015 Sep;45(9):2446-56. doi: 10.1002/eji.201545502. Epub 2015 Aug 19. Review.

18.
19.

From excess adiposity to insulin resistance: the role of free fatty acids.

Capurso C, Capurso A.

Vascul Pharmacol. 2012 Sep-Oct;57(2-4):91-7. doi: 10.1016/j.vph.2012.05.003. Epub 2012 May 15. Review.

PMID:
22609131
20.

Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals.

Targher G, Rossi AP, Zamboni GA, Fantin F, Antonioli A, Corzato F, Bambace C, Pozzi Mucelli R, Zamboni M.

J Endocrinol Invest. 2012 Sep;35(8):748-53. Epub 2011 Oct 4.

PMID:
21979274

Supplemental Content

Support Center